OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AMES56

Alexandria Medical Services SAE

Healthcare Facilities & ServicesVerified

Alexandria Medical Services SAE maintains a strong liquidity position, with a current ratio of 1.55 and cash and equivalents amounting to EGP 41,096,370. The company's debt-to-equity ratio is 0.06, indicating a conservative capital structure with minimal leverage. The company's profitability is robust, with a return on equity (ROE) of 19.94% and a return on assets (ROA) of 12.89%. These figures exceed the typical performance metrics for healthcare facilities, suggesting efficient asset utilization and strong earnings generation. The company's revenue is concentrated in a single geographic market, Egypt, and its operations are primarily focused on inpatient and outpatient medical services. There is no disclosed segmental breakdown, but the hospital's specialization in multiple medical fields suggests a diversified service offering within the healthcare sector. Looking ahead, the company is expected to maintain its growth trajectory, supported by a strong operating cash flow of EGP 21,088,850 and a free cash flow of EGP 48,431,350. These figures suggest the company has the financial flexibility to reinvest in its operations or return value to shareholders. The company's risk profile is low, with no immediate liquidity or dilution flags detected. The low dilution risk is further supported by the absence of any recent share issuance or shelf registration activity. The company's conservative debt levels and strong cash position reduce the likelihood of financial distress. Recent filings and transcripts do not indicate any material changes in the company's operations or strategic direction. The company continues to focus on its core hospital operations and has not disclosed any major expansion plans or new ventures.

30-day price · AMES+30.81 (+130.9%)
Low$22.79High$65.87Close$54.34As of12 May, 00:00 UTC
Profile
CompanyAlexandria Medical Services SAE
TickerAMES.CA
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Alexandria Medical Services SAE operates a hospital offering diagnostic and treatment services across multiple medical specializations, including gynecology, general surgery, pediatrics, and internal disease, among others.

Classification. Alexandria Medical Services SAE is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Alexandria Medical Services SAE maintains a strong liquidity position, with a current ratio of 1.55 and cash and equivalents amounting to EGP 41,096,370. The company's debt-to-equity ratio is 0.06, indicating a conservative capital structure with minimal leverage. The company's profitability is robust, with a return on equity (ROE) of 19.94% and a return on assets (ROA) of 12.89%. These figures exceed the typical performance metrics for healthcare facilities, suggesting efficient asset utilization and strong earnings generation. The company's revenue is concentrated in a single geographic market, Egypt, and its operations are primarily focused on inpatient and outpatient medical services. There is no disclosed segmental breakdown, but the hospital's specialization in multiple medical fields suggests a diversified service offering within the healthcare sector. Looking ahead, the company is expected to maintain its growth trajectory, supported by a strong operating cash flow of EGP 21,088,850 and a free cash flow of EGP 48,431,350. These figures suggest the company has the financial flexibility to reinvest in its operations or return value to shareholders. The company's risk profile is low, with no immediate liquidity or dilution flags detected. The low dilution risk is further supported by the absence of any recent share issuance or shelf registration activity. The company's conservative debt levels and strong cash position reduce the likelihood of financial distress. Recent filings and transcripts do not indicate any material changes in the company's operations or strategic direction. The company continues to focus on its core hospital operations and has not disclosed any major expansion plans or new ventures.
Key takeaways
  • Alexandria Medical Services SAE has a strong liquidity position with a current ratio of 1.55 and significant cash reserves.
  • The company's ROE of 19.94% and ROA of 12.89% indicate strong profitability and efficient asset use.
  • The company's operations are concentrated in Egypt, with no disclosed segmental diversification.
  • The company is expected to maintain its growth trajectory, supported by strong operating and free cash flows.
  • The company's risk profile is low, with no immediate liquidity or dilution concerns.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEGP
Revenue$467.9M
Gross profit$153.3M
Operating income$68.6M
Net income$55.0M
R&D
SG&A
D&A
SBC
Operating cash flow$21.1M
CapEx-$20.5M
Free cash flow$48.4M
Total assets$427.1M
Total liabilities$151.1M
Total equity$276.0M
Cash & equivalents$41.1M
Long-term debt$15.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$276.0M
Net cash$25.6M
Current ratio1.6
Debt/Equity0.1
ROA12.9%
ROE19.9%
Cash conversion38.0%
CapEx/Revenue-4.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricAMESActivity
Op margin14.7%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin11.8%14.7% medp25 11.7% · p75 28.1%below median
Gross margin32.8%19.7% medp25 19.7% · p75 39.8%above median
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-4.4%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity6.0%71.3% medp25 19.0% · p75 91.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 14:09 UTC#c6d76f97
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 14:12 UTCJob: b698488d